摘要
微血管性心绞痛(MVA)作为缺血性心脏病的主要类型,因发病率较高而受到临床广泛关注,目前MVA的治疗主要延续冠心病的治疗策略,但疗效不尽如人意。本文从胡镜清教授的病机兼化理论出发,在仔细研读古代关于胸痹文献资料的基础上,结合当今MVA的最新研究成果,初步探索出MVA以痰瘀互结为核心病机,并呈现出早期兼寒邪而化,中期兼痰、瘀而化,后期兼正虚而化的演变规律,希冀能助力于临床治疗。
Microvascular angina(MVA),as the main type of ischemic heart disease,has received widespread clinical attention due to its high incidence.The current treatment of MVA mainly continues the treatment strategy of coronary heart disease,but the effect is not satisfactory.Based on professor HU Jingqing’s theory of pathogenesis and transformation,and careful study of ancient literature on chest obstruction,combined with the latest research results of MVA,this study initially explored that the core pathogenesis of MVA was intermingled phlegm and blood stasis,which evolved the law of the combination of cold pathogens in the early stage,phlegm and blood stasis in the middle stage,and deficiency in the later stage,aiming to be beneficial to the clinical treatment of the disease.
作者
谢蓓莉
刘明旺
别玉龙
宋博策
赵福海
XIE Beili;LIU Mingwang;BIE Yulong;SONG Boce;ZHAO Fuhai(Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100091, China;National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China)
出处
《中医药学报》
CAS
2022年第4期9-11,共3页
Acta Chinese Medicine and Pharmacology
基金
国家重点研发计划(2019YFC1708501)。
关键词
微血管性心绞痛
痰瘀互结
络病
Microvascular angina
Intermingled phlegm and blood stasis
Collateral disease
